Skip to main content
. 2007 Feb 22;117(3):739–745. doi: 10.1172/JCI30400

Figure 2. PKCε ASO reduces fasting concentration of insulin without changes in plasma glucose, intrahepatic triglyceride, or DAG.

Figure 2

(A) Fasting plasma glucose. (B) Fasting plasma insulin. **P < 0.001 versus saline; ‡P < 0.01 versus control ASO. (C) Hepatic triglyceride content. (D) Intrahepatic total DAG.